Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis model.
about
Investigational drugs to treat methicillin-resistant Staphylococcus aureusHost factors that contribute to recurrent staphylococcal skin infectionDetection of Alpha-Toxin and Other Virulence Factors in Biofilms of Staphylococcus aureus on Polystyrene and a Human Epidermal ModelVLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation.The psmα locus regulates production of Staphylococcus aureus alpha-toxin during infectionTargeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections.Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.Insights into the Staphylococcus aureus-host interface: global changes in host and pathogen gene expression in a rabbit skin infection model.ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation.CD36 Is Essential for Regulation of the Host Innate Response to Staphylococcus aureus α-Toxin-Mediated Dermonecrosis.MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers.Immunomodulation and Disease Tolerance to Staphylococcus aureusStaphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.Staphylococcus aureus-dependent septic arthritis in murine knee joints: local immune response and beneficial effects of vaccination.Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumoniaThe Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.Mechanisms of neutralization of a human anti-α-toxin antibody.Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.α-Toxin Regulates Local Granulocyte Expansion from Hematopoietic Stem and Progenitor Cells in Staphylococcus aureus-Infected Wounds.Neutralizing α-toxin accelerates healing of Staphylococcus aureus-infected wounds in normal and diabetic mice.Innate Sex Bias of Staphylococcus aureus Skin Infection Is Driven by α-Hemolysin.Individual variation is the key to the development of a vaccine against Staphylococcus aureus: a comparative study between mice lineages.Deciphering the Pathological Role of Staphylococcal α-Toxin and Panton-Valentine Leukocidin Using a Novel Ex Vivo Human Skin Model.Alpha-Toxin Contributes to Biofilm Formation among Staphylococcus aureus Wound Isolates.Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development.Liposomal Therapy Attenuates Dermonecrosis Induced by Community-Associated Methicillin-Resistant Staphylococcus aureus by Targeting α-Type Phenol-Soluble Modulins and α-Hemolysin
P2860
Q26780246-6DAD6E06-E962-471D-8D76-E66417E449FBQ27005777-921F6390-BB48-4807-AB7F-5C394C98F81FQ28552176-DDAF6A09-623D-40D8-A923-F06E83110E69Q33677615-E8A7F36A-D92B-4A6F-8C97-2F9CEFBADFC5Q34058980-A07796F5-3B27-4C62-83CB-239E36421298Q34396053-4817B4DD-6B11-4A75-BEAF-A2FC7E4CC2DBQ34916584-1D5DD8AB-BDE0-4E13-8C02-F353208F7ECAQ34922452-AF0D1B71-644C-4710-8E96-034CFA9D3C36Q35031839-1319FE54-E466-4F89-A9DB-253EFC7F16AFQ35125561-80279D67-F50D-4C80-9B8A-725025021D7AQ35169008-634CDE7D-7C7A-46DC-BA2D-8F1CA44D02C9Q35988737-9FEAD6E6-6A4D-4F7F-8D50-0F84A7DF2841Q36032570-B6F3D7C6-4FA9-47EB-93E0-5F5B3F733866Q36409380-A23B8064-E784-4C46-89A5-C030F88FA0D7Q37203734-FAF7B81A-D0AF-4E8F-9FA3-C0A3BF6E0F8EQ37287845-4E77349B-AE73-488D-956A-6918BFFDA55CQ37454396-5034A632-6972-42C2-9DD8-50A2FA363497Q37544870-27C8A7AD-BBDA-4BB1-BDBB-0FF2F32BDB50Q38633668-D1428516-7248-45C6-8A4F-7AA111FB2322Q38957590-BF61A093-AAA8-41A8-9AA9-5563E3339CA4Q39264668-FEB15693-0F5E-4C74-A69C-022C1DE8A0BAQ40124323-CA2B9BDA-DBDE-498E-BF8A-7BC299B7EEF3Q47193259-96A60B6C-9DDC-40BB-BFD2-2EF962F62641Q47340403-48193AE7-0DBE-439A-B939-F88686721BB5Q54246789-F5BB9BC2-76C8-41EF-BAFE-FF29F2E2587BQ54999129-E0C2CC3E-750F-4ACC-A6B1-5E6C409E9B18Q55043754-DD61948F-1728-477F-92BE-E159D87DA2E6Q55246404-BCD56F94-DC4C-43B0-8522-542C374695B8Q58481390-7BA50AF7-4B3A-431A-B0E2-04B2570915ED
P2860
Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis model.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Staphylococcus aureus alpha to ...... a murine dermonecrosis model.
@ast
Staphylococcus aureus alpha to ...... a murine dermonecrosis model.
@en
type
label
Staphylococcus aureus alpha to ...... a murine dermonecrosis model.
@ast
Staphylococcus aureus alpha to ...... a murine dermonecrosis model.
@en
prefLabel
Staphylococcus aureus alpha to ...... a murine dermonecrosis model.
@ast
Staphylococcus aureus alpha to ...... a murine dermonecrosis model.
@en
P2093
P2860
P1433
P1476
Staphylococcus aureus alpha to ...... a murine dermonecrosis model.
@en
P2093
Agnieszka Sadowska
Bret R Sellman
Christine Tkaczyk
Geoffrey L Stephens
Jamese J Hilliard
JoAnn Suzich
Melissa M Hamilton
Terrence O'Day
Vivekananda Datta
P2860
P304
P356
10.1371/JOURNAL.PONE.0075103
P407
P577
2013-10-02T00:00:00Z